Hier ist das Video Statement #insulinconsensus Wir, und vermutlich ALLE möchten, dass sich die Situation in Krisengebieten ändert! Was kann man tun? Als Erstes auf jeden Fall die Stimme erheben! https://t.co/dwhbTlaH8S SEI DABEI! Teile deine Stimme!
https://t.co/gEWhOlyLsP
He not only thought big, but he also put it all into action. He set new standards in terms of advovacy for diabetes. Through his commitment a worldwide movement developed, creating countless wonderful projects and relationships. This will always live on. #payitforward
We went beyond HbA1c & technology to discuss diabetes distress, stigma, peer support, burnout, Language Matters, and what truly person-centered diabetes care shud look like, thanks @James_Ridgeway_
A powerful, honest conversation you do not want to miss
https://t.co/5u9tqUt6VS
Lived experience matters. Deep expertise in medicines R&D amplifies it.
For the second year, we’re fully sponsoring one INPACT Associate for the @eupatitraining Programme 🏅🌍
Stay tuned to find out who won!
The updated INSULIN Act would expand the $35 copay cap and move us closer to a future where no one has to ration insulin. But it won't pass without public pressure. If you live in the USA, email your Senators and urge them to support the INSULIN Act: https://t.co/D8ZYT5wCO0
Ahhhh… so delighted to see this study out there on the wild
So sad I was self-advocating in a void 20 years ago.
Check out the post and if you’re eligible please do consider signing up 💙
As insulin pump access becomes increasingly resolved through the judicial system in Uruguay, Global Advocate Sebastian Haro reflects on his personal experience navigating the process and the current diabetes landscape in Uruguay. Read more on our blog: https://t.co/e6y0wSxDIj
Carb counting AI at #ATTD2026
• The average human carb-counting error is ±15.4g for a 72g meal.
• A study of 241 meals showed that the accuracy of different AI carb-counting tools varies significantly.
Phenomenal session by @Tims_Pants on AI in diabetes care at #ATTD2026.
Some of my key takeaways:
• Generic LLMs (ChatGPT, Grok, etc.) cannot safely provide insulin dosing recommendations.
• When given weeks of CGM data, Al skips over large chunks and fabricates summaries.
Tech Updates fr Dr Girish N🌱
1️⃣STELO, T2
🟰Sees the impact of food choices
🟰 Focuses on trends, not single spikes → less anxiety
🟰 Turns insights into behavioral change✨
2️⃣Next‑Gen
🟰 <8% MARDaccuracy; target 90–130mg/dL
#dedoc° #voices#ATTD2026@ATTDconf@dedocDE
The #dedoc° Silent Auction in support of the Global Summit to End Diabetes Stigma just launched at the #dedoc° symposium at ATTD Barcelona - Place Your Bid!
https://t.co/nKbbAtffYx
#ATTD#ATTD2026#EndDiabetesStigma#diabetes
When the Media Gets It Right 🗞️
T1D journalist Harry Bligh reminds us that diabetes stories online are often reduced to sugar jokes.⚠️
But the real stories are HUMAN.💙
When lived experience is heard, stigma is challenged!✨
#dedoc° #voices#ATTD2026@ATTDconf@dedocDE
Final day of #SpareARose🌹
With over 60 individual donors, this community showed up with generosity and heart. While a corporate match wasn’t possible this year, the impact of collective giving is real & we’re deeply grateful
Thank you for standing w/us
https://t.co/BOtIRJxWz2
Day 27 of #SpareARose 🌹
One day to go.
One last chance to spare a rose and help move insulin where it’s needed most.
Join us today.
🔗 [https://t.co/BOtIRJxWz2]
Day 25 of #SpareARose 🌹
This is what collective action looks like — people choosing to care, to act, to change lives.
A few days left. Still time to join.
🔗 [https://t.co/BOtIRJxWz2]
Day 23 of #SpareARose 🌹
Quiet days don’t stop real movements.
There’s still time. Still need. Still impact to make.
Join us.
🔗 [https://t.co/BOtIRJxWz2]